The ESPARA study is a multicenter observational research project aiming to monitor, over a three-year period, the evolution of sexual symptoms in male sexual offenders with paraphilia, divided into three groups: receiving antiandrogen treatment, receiving selective serotonin reuptake inhibitors (SSRIs), or no pharmacological treatment. The primary objective is to assess changes in sexual desire intensity and deviant sexual behaviors, while secondary objectives include relapse rates, the role of psychiatric comorbidities, treatment tolerability, and various clinical, cognitive, and life-history factors.
Men suffering from paraphilias (DSM-5 criteria),
Aged 18 to 65 years,
Sexual offenders (offense or sexual assault including exhibitionism, rape, sexual touching, incest, possession of pedopornographic video material) (severity level 1 to 6 according to WFSBP recommendations),
Subject who has given consent,
Subject in prison (regardless of the reason),
Subject under guardianship (patients under legal supervision may, however, be included),
Subjects who have committed a sexual offense and do not meet the DSM-5 criteria for paraphilia."